GUO Zixuan, XU Meng, WU Ju, LI Jianxiong, ZHAO Xuelin, ZHAO Ziyi. Effect of artificial total femoral replacement in treatment of femoral malignant tumors[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(2): 114-120, 127. DOI: 10.3969/j.issn.2095-5227.2023.02.003
Citation: GUO Zixuan, XU Meng, WU Ju, LI Jianxiong, ZHAO Xuelin, ZHAO Ziyi. Effect of artificial total femoral replacement in treatment of femoral malignant tumors[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(2): 114-120, 127. DOI: 10.3969/j.issn.2095-5227.2023.02.003

Effect of artificial total femoral replacement in treatment of femoral malignant tumors

More Information
  • Author Bio:

    GUO Zixuan. Email: gzx301@126.com

  • Corresponding author:

    XU Meng. Email: 13501175839@163.com

  • Received Date: July 20, 2022
  • Available Online: February 19, 2023
  •   Background  Artificial total femoral replacement has played an important role in limb reconstruction, but due to its difficulty in surgery and the particularity of prostheses, there are relatively few reports.
      Objective  To investigate the application value and efficacy of the combined artificial total femur prosthesis in patients with femoral malignancy.
      Methods  Clinical data about 12 patients with bone malignant tumors who underwent artificial total femoral replacement in the First Medical Center of Chinese PLA General Hospital from January 2014 to January 2018 were retrospectively analyzed. The Watson-Jone incision was mainly used for surgery, with the distal end extending to the lateral side of the patella revealing the full length of the femur, and the combination of prosthesis replacements was performed. Pain was evaluated by visual analogue scale (VAS) before operation and at 3 months after operation. At the last follow-up, the lower extremity function (MSTS) score, hip function Harris score (HHS), Oxford score and University Knee Score (OKS) were used to evaluate lower limb function, and imaging technologies were used to review tumor recurrence and metastasis.
      Results  There were 5 males and 7 females, with the average age of 27.75 years (range: 11-69 years). The course of disease ranged from 2 to 8 months, with an average of 4.4 months. There were 8 cases of osteosarcoma (7 cases of Enneking ⅡB stage, 1 case of Ⅲ stage), 3 cases of Ewing sarcoma (Enneking ⅡB stage), and 1 case of renal carcinoma with femoral metastases and pathological fractures. All patients were followed up for 17-81 months, with an average of 37.8 months. Among them, 2 patients died of multiple organ failure due to tumor metastasis, and 1 patient with metastatic cancer died due to the progression of the primary tumor and ineffective treatment. One case of Ewing sarcoma developed bone metastases and survived with the tumor. All patients had no local recurrence, infection, dislocation and other complications. The 5-year overall survival rate was 69.44%, and the tumor-free survival was 35 months. The 5-year overall survival rate was 69.44%, and the median tumor-free survival was 35 months. The VAS score at 3 months after surgery was significantly improved compared with the preoperative score (2.0 ± 1.08 vs 5.42 ± 1.32, P<0.001). At the last follow-up, the MSTS score, HHS score and Oxford University knee joint function score were significantly higher compared with before surgery (20.92 ± 3.25 vs 11.17 ± 3.26, P=0.002; 68.33 ± 12.19 vs 29.75 ± 11.40, P=0.003; 32.50 ± 7.48 vs 15.83 ± 5.27, P=0.002).
      Conclusion  Artificial total femur replacement can restore the anatomy of patients with primary tumor resection, rebuild the femur, preserve the patient's lower limb movement and weight-bearing capacity, and significantly improve the patient's quality of life.
  • [1]
    Pan K,Chan W,Shanmugam P,et al. Large volume osteosarcomas of the femur treated with total femoral replacement[J]. Malays Orthop J,2014,8(1): 32-36. doi: 10.5704/MOJ.1403.015
    [2]
    Kakimoto T,Matsumine A,Asanuma K,et al. The clinical outcomes of total femur prosthesis in patients with musculoskeletal tumors[J]. SICOT J,2019,5: 23. doi: 10.1051/sicotj/2019020
    [3]
    Ruggieri P,Bosco G,Pala E,et al. Local recurrence,survival and function after total femur resection and megaprosthetic reconstruction for bone sarcomas[J]. Clin Orthop Relat Res,2010,468(11): 2860-2866. doi: 10.1007/s11999-010-1476-4
    [4]
    Uustal H,Meier RH 3rd. Pain issues and treatment of the person with an amputation[J]. Phys Med Rehabil Clin N Am,2014,25(1): 45-52. doi: 10.1016/j.pmr.2013.09.008
    [5]
    姜爽. 恶性肿瘤截肢术后幻肢痛的影响因素及相关脑影像学改变的预测效能研究[D]. 沈阳: 中国医科大学, 2021.
    [6]
    Gorter J,Ploegmakers JJW,Ten Have BLEF,et al. The push-through total femoral prosthesis offers a functional alternative to total femoral replacement:a case series[J]. Int Orthop,2017,41(11): 2237-2244. doi: 10.1007/s00264-017-3467-5
    [7]
    Li Y,Yang YK,Huang Z,et al. Bone defect reconstruction with autologous bone inactivated with liquid nitrogen after resection of primary limb malignant tumors:an observational study[J]. Medicine (Baltimore),2020,99(24): e20442.
    [8]
    Hindiskere S,Doddarangappa S,Chinder PS. What are the challenges and complications of sterilizing autografts with liquid nitrogen for malignant bone tumors?A preliminary report[J]. Clin Orthop Relat Res,2020,478(11): 2505-2519. doi: 10.1097/CORR.0000000000001347
    [9]
    王振,刘继军. 肿瘤膝关节假体与大段同种异体骨重建治疗膝关节周围肿瘤疗效对比[J]. 实用骨科杂志,2019,25(11): 978-981. doi: 10.13795/j.cnki.sgkz.2019.11.005
    [10]
    葛立业,李东升,杨玉鹏,等. 瘤段完整切除联合人工假体重建保肢术治疗股骨远端骨肉瘤患者的中期随访研究[J]. 临床研究,2020,28(3): 1-2.
    [11]
    Bolia IK,Savvidou OD,Kang HP,et al. Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece[J]. Eur J Orthop Surg Traumatol,2021,31(8): 1631-1638. doi: 10.1007/s00590-021-02921-5
    [12]
    毛团员,易倩,婷游辉. 人工髋关节置换术与内固定治疗髋部骨折对患者髋关节功能评分的影响[J]. 透析与人工器官,2022,33(1): 26-28. doi: 10.3969/j.issn.1005-0809.2022.01.008
    [13]
    Demetriou C,Webb J,Sedgwick P,et al. Preoperative factors affecting the patient-reported outcome measures following total knee replacement:socioeconomic factors and preoperative OKS have a clinically meaningful effect[J]. J Knee Surg,2022,35(9): 940-948. doi: 10.1055/s-0040-1721089
    [14]
    Jones KB,Griffin AM,Chandrasekar CR,et al. Patient-oriented functional results of total femoral endoprosthetic reconstruction following oncologic resection[J]. J Surg Oncol,2011,104(6): 561-565. doi: 10.1002/jso.22003
    [15]
    Amanatullah DF,Trousdale RT,Hanssen AD,et al. Non-oncologic total femoral arthroplasty:retrospective review[J]. J Arthroplasty,2014,29(10): 2013-2015. doi: 10.1016/j.arth.2014.05.012
    [16]
    Hofmann GO,Kirschner MH,Wangemann T,et al. Infections and immunological hazards of allogeneic bone transplantation[J]. Arch Orthop Trauma Surg,1995,114(3): 159-166. doi: 10.1007/BF00443390
    [17]
    Henderson ER,O'Connor MI,Ruggieri P,et al. Classification of failure of limb salvage after reconstructive surgery for bone tumours:a modified system Including biological and expandable reconstructions[J]. Bone Joint J,2014,96-B(11): 1436-1440. doi: 10.1302/0301-620X.96B11.34747
    [18]
    Yang YH,Chen JX,Chen QY,et al. Total femur replacement with 18 years of follow-up:a case report[J]. World J Clin Cases,2022,10(15): 4957-4963. doi: 10.12998/wjcc.v10.i15.4957
    [19]
    Toepfer A,Harrasser N,Petzschner I,et al. Is total femoral replacement for non-oncologic and oncologic indications a safe procedure in limb preservation surgery?A single center experience of 22 cases[J]. Eur J Med Res,2018,23(1): 5. doi: 10.1186/s40001-018-0302-4
    [20]
    吴凡,方向,郎志刚,等. 人工全股骨置换术治疗股骨恶性肿瘤[J]. 中国修复重建外科杂志,2019,33(1): 18-22.
    [21]
    Putman S,Migaud H,Saragaglia D,et al. Total femur replacement in non-oncologic indications:functional and radiological outcomes from a French survey with a mean 6 years' follow-up[J]. Orthop Traumatol Surg Res,2019,105(4): 591-598. doi: 10.1016/j.otsr.2018.12.013
    [22]
    Ramanathan D,Siqueira MB,Klika AK,et al. Current concepts in total femoral replacement[J]. World J Orthop,2015,6(11): 919-926. doi: 10.5312/wjo.v6.i11.919
    [23]
    Sarrazin J,Dartus J,Martinot P,et al. Salvage reconstruction of hip ligaments using absorbable material to treat recurrent instability of revision THA without abductor mechanism[J]. Orthop Traumatol Surg Res,2021,107(1): 102783. doi: 10.1016/j.otsr.2020.102783
    [24]
    Ahmed AR. Total femur replacement[J]. Arch Orthop Trauma Surg,2010,130(2): 171-176. doi: 10.1007/s00402-009-0945-2
    [25]
    Morri M,Raffa D,Vigna D,et al. Which factors are associated with the functional recovery in patients undergoing endoprosthetic knee reconstruction following bone tumour resection?- A observational study[J]. Arch Physiother,2018,8: 11. doi: 10.1186/s40945-018-0052-1
    [26]
    Du ZY,Tang S,Yang RL,et al. Use of an artificial ligament decreases hip dislocation and improves limb function after total femoral prosthetic replacement following femoral tumor resection[J]. J Arthroplasty,2018,33(5): 1507-1514. doi: 10.1016/j.arth.2017.12.017
    [27]
    Katrak P,O'Connor B,Woodgate I. Rehabilitation after total femur replacement:a report of 2 cases[J]. Arch Phys Med Rehabil,2003,84(7): 1080-1084. doi: 10.1016/S0003-9993(03)00041-8
  • Cited by

    Periodical cited type(4)

    1. 冼颖菊,方晓敏. 正念干预在下肢截肢术后患者中的应用效果. 医药前沿. 2025(03): 83-85 .
    2. 崔路宽,孙扬,金韬,刘巍峰. 全股骨假体置换在青少年股骨恶性肿瘤患者保肢中的应用效果. 中国骨与关节杂志. 2025(02): 100-106 .
    3. 向宇燕,徐建国,詹红招,蒋臻. MRI扫描预测膝关节周围肉瘤关节内受累的价值. 浙江创伤外科. 2024(09): 1761-1764 .
    4. 刘霄龙,李庄严,张良,张士杰. 人工股骨头置换术治疗股骨转移瘤患者的疗效. 癌症进展. 2024(24): 2730-2733 .

    Other cited types(1)

Catalog

    Article Metrics

    Article views (327) PDF downloads (26) Cited by(5)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return